T-cell Acute Lymphoblastic Lymphoma Clinical Trials

8 clinical trials for T-cell Acute Lymphoblastic Lymphoma across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen — RECRUITING · PHASE1
• Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies — RECRUITING · PHASE1
• Universal 4SCAR7U Targeting CD7-positive Malignancies — RECRUITING · PHASE1
• Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells — RECRUITING · PHASE1
• Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma — RECRUITING · PHASE1
• Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells — ACTIVE_NOT_RECRUITING · PHASE1
• Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies — OTHER · PHASE1
• Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances — OTHER · PHASE1

Refine this search